Is there a generic for Cefonicid sodium?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Cefonicid sodium, referencing the brand MONOCID. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Cefonicid sodium?

MONOCID (NDA 050579, GLAXOSMITHKLINE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cefonicid sodium are approved?

Cefonicid sodium is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Cefonicid sodium

Cefonicid sodium is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MONOCID · NDA 050579

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
MONOCID×4	GLAXOSMITHKLINE	NDA 050579	—	May 23, 1984

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
MONOCID	GLAXOSMITHKLINE	ANDA 063295	—	Jul 26, 1993

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cefonicid sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo